文献速递产科母胎医学

极早发型胎儿生长受限(≤26周)的围产期与母亲结局:系统评价与Meta分析

Perinatal and maternal outcomes of extremely early-onset fetal growth restriction (≤ 26 weeks): systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-11-14

该系统评价与Meta分析纳入14项研究共2818例单胎妊娠,其中13项2573例进入Meta分析,评估妊娠≤26周诊断的极早发型胎儿生长受限的围产期与母亲结局。合并分析显示围产期死亡发生率为16.0%,早产≤32周为54.6%,剖宫产为45.6%,复合不良围产期结局为30.5%。作者结论认为此类妊娠面临遗传与结构异常及不良母亲与围产期结局的高风险。

要点

  • 极早发型胎儿生长受限(≤26周)孕妇中围产期死亡合并发生率为16.0%。
  • 早产≤32周与≤28周分别占54.6%和23.3%,剖宫产占45.6%。
  • 复合不良围产期结局影响30.5%的婴儿,神经病学并发症报告率为38.3%。

核心结论

  • 极早发型胎儿生长受限(≤26周)妊娠面临遗传与结构异常以及不良母亲与围产期结局的高风险。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、EMBASE和Cochrane数据库,纳入报告妊娠≤26周诊断胎儿生长受限的单胎妊娠结局的研究,共纳入14项研究2818例妊娠,其中13项2573例进入Meta分析。
  • 采用随机效应模型对比例进行Meta分析。

主要发现

  • 全部极早发型胎儿生长受限胎儿中,围产期死亡、宫内死亡和新生儿死亡分别发生于16.0%(95%CI 8.1-26.0%)、8.8%(95%CI 4.0-15.2%)和6.2%(95%CI 3.0-10.4%)的病例。
  • 早产≤32周和≤28周分别占54.6%(95%CI 23.1-84.2%)和23.3%(95%CI 4.7-50.3%),剖宫产占45.6%(95%CI 32.6-58.9%)。
  • 复合不良围产期结局影响30.5%(95%CI 19.4-42.8%)的婴儿,神经病学并发症报告率为38.3%(95%CI 9.8-72.1%)。
  • 在看似孤立的极早发型胎儿生长受限妊娠中,围产期死亡发生于14.3%(95%CI 6.2-25.0%),早产≤32周和≤28周分别占54.8%(95%CI 49.8-59.7%)和23.6%(95%CI 4.9-50.6%),复合不良围产期结局占28.8%(95%CI 20.4-38.0%),神经病学并发症为38.3%(95%CI 9.8-72.1%)。
  • 在因遗传或结构异常导致的极早发型胎儿生长受限妊娠中,围产期死亡发生于17.6%(95%CI 6.2-33.3%),复合不良围产期结局占19.3%(95%CI 7.6-34.9%)。

关键数值与推荐

  • 极早发型胎儿生长受限定义为妊娠≤26周诊断的胎儿生长受限。
  • 主要结局为围产期死亡,定义为宫内死亡与新生儿死亡之和。
  • 亚组分析按胎儿生长受限病因进行:看似孤立性胎儿生长受限、按Delphi标准定义的胎儿生长受限、或因遗传或结构异常导致的胎儿生长受限。
  • 在看似孤立性胎儿生长受限中,按用于定义极早发型的孕周切点、诊断时孕周、分娩时孕周及多普勒异常进行亚组分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the perinatal and maternal outcomes of singleton pregnancies complicated by extremely early-onset fetal growth restriction (FGR), defined as FGR diagnosed ≤ 26 weeks of gestation. METHODS: MEDLINE, EMBASE and Cochrane databases were searched for studies reporting the outcome of singleton pregnancies complicated by FGR diagnosed ≤ 26 weeks of gestation. The primary outcome was perinatal death (PND), defined as the sum of intrauterine death (IUD) and neonatal death (NND). Secondary outcomes included genetic anomaly, structural anomaly, infection, pre-eclampsia (PE), IUD, NND, termination of pregnancy, preterm birth (PTB) ≤ 32 and ≤ 28 weeks of gestation, Cesarean delivery, vaginal delivery, admission to the neonatal intensive care unit, abnormal brain imaging, respiratory distress syndrome, bronchopulmonary dysplasia, necrotizing enterocolitis, neonatal sepsis, neurological morbidity, composite adverse perinatal outcome (CAPO) and intact survival. All outcomes were explored in the overall population of pregnancies complicated by extremely early-onset FGR. A subset of outcomes was explored in a subgroup analysis of FGR etiology: apparently isolated FGR, FGR defined according to the Delphi criteria, or FGR due to genetic or structural anomaly. Among those with apparently isolated FGR, subgroup analyses were conducted according to the gestational-age cut-off used to define extremely early onset, gestational age at diagnosis, gestational age at birth and presence of abnormal Doppler findings. Random-effects meta-analysis of proportions was used to combine the data. RESULTS: Fourteen studies (2818 pregnancies) were included in the systematic review, of which 13 (2573 pregnancies) were included in the meta-analysis. Among all fetuses with extremely early-onset FGR, PND, IUD and NND occurred in 16.0% (95% CI, 8.1-26.0%), 8.8% (95% CI, 4.0-15.2%) and 6.2% (95% CI, 3.0-10.4%) of cases, respectively. PTB ≤ 32 and ≤ 28 weeks of gestation complicated 54.6% (95% CI, 23.1-84.2%) and 23.3% (95% CI, 4.7-50.3%) of pregnancies, respectively, while 45.6% (95% CI, 32.6-58.9%) underwent Cesarean delivery. CAPO affected 30.5% (95% CI, 19.4-42.8%) of infants, while neurological morbidity was reported in 38.3% (95% CI, 9.8-72.1%). Among pregnancies complicated by apparently isolated extremely early-onset FGR, PND occurred in 14.3% (95% CI, 6.2-25.0%) of cases. PTB ≤ 32 and ≤ 28 weeks of gestation occurred in 54.8% (95% CI, 49.8-59.7%) and 23.6% (95% CI, 4.9-50.6%) of cases, respectively. CAPO occurred in 28.8% (95% CI, 20.4-38.0%) of infants, while neurological morbidity was present in 38.3% (95% CI, 9.8-72.1%). In pregnancies complicated by extremely early-onset FGR due to a genetic or structural anomaly, PND occurred in 17.6% (95% CI, 6.2-33.3%) and CAPO in 19.3% (95% CI, 7.6-34.9%). CONCLUSION: Pregnancies with extremely early-onset FGR are at high risk of genetic and structural anomalies, as well as adverse maternal and perinatal outcomes. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Piergianni M, Della Valle L, Khalil A, et al. Perinatal and maternal outcomes of extremely early-onset fetal growth restriction (≤ 26 weeks): systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2025. PMID: 41235926. doi:10.1002/uog.70124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。